Convalescent plasma for COVID-19. A randomized clinical trial

…, HSM Ammerlaan, EM van Leeuwen-Segarceanu… - MEDRxiv, 2020 - medrxiv.org
Structured abstract for full paper Background After recovery from COVID-19, most patients
have anti-SARS-CoV-2 neutralizing antibodies. Their convalescent plasma could be an …

[HTML][HTML] Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection

…, EM van LeeuwenSegarceanu… - Nature …, 2021 - nature.com
In a randomized clinical trial of 86 hospitalized COVID-19 patients comparing standard care
to treatment with 300mL convalescent plasma containing high titers of neutralizing SARS-…

Screening Hodgkin lymphoma survivors for radiotherapy induced cardiovascular disease

EM van Leeuwen-Segarceanu, WJW Bos… - Cancer treatment …, 2011 - Elsevier
Long term prognosis of Hodgkin lymphoma (HL) survivors is affected by late toxicity of
radiotherapy and chemotherapy. Cardiovascular complications of radiotherapy have been shown …

Assessment of valvular disorders in survivors of Hodgkin's lymphoma treated by mediastinal radiotherapy±chemotherapy

…, MM Roos, EM van Leeuwen-Segarceanu… - The American journal of …, 2016 - Elsevier
As the number of Hodgkin's lymphoma (HL) survivors grows, understanding long-term
complications becomes more important. Mediastinal radiotherapy (MRT) seems to cause valvular …

Comparison of two instruments measuring carotid-femoral pulse wave velocity: Vicorder versus SphygmoCor

EM van Leeuwen-Segarceanu, WF Tromp… - Journal of …, 2010 - journals.lww.com
Background The carotid-femoral pulse wave velocity (PWVcf) is used as an indicator of
arterial stiffness. It is often measured using applanation tonometry, for instance with the …

Progressive muscle atrophy and weakness after treatment by mantle field radiotherapy in Hodgkin lymphoma survivors

EM van Leeuwen-Segarceanu, LDA Dorresteijn… - International Journal of …, 2012 - Elsevier
PURPOSE: To describe the damage to the muscles and propose a pathophysiologic mechanism
for muscle atrophy and weakness after mantle field radiotherapy in Hodgkin lymphoma …

Results of the Phase III Randomized Iskia Trial: Isatuximab-Carfilzomib-Lenalidomide-Dexamethasone Vs Carfilzomib-Lenalidomide-Dexamethasone As Pre …

…, J Martinez-Lopez, EM van Leeuwen-Segarceanu… - Blood, 2023 - Elsevier
… Duin PhD 14 , Mattia D'Agostino MD 2 1 , Joaquin Martinez-Lopez MD PhD 15 , Elena M.
van Leeuwen-Segarceanu MD PhD 16 , Paola Tacchetti MD PhD 17 , Niels WCJ van de Donk …

Arterial stiffness is increased in Hodgkin lymphoma survivors treated with radiotherapy

EM van Leeuwen-Segarceanu… - Leukemia & …, 2013 - Taylor & Francis
Radiotherapy has been associated with an increased risk for cardiovascular disease (CVD)
in Hodgkin lymphoma survivors (HLS). Identifying subjects most likely to develop these …

[HTML][HTML] Outpatient convalescent plasma therapy for high-risk patients with early COVID-19: a randomized placebo-controlled trial

…, F Karim, E van Leeuwen-Segarceanu… - Clinical Microbiology …, 2023 - Elsevier
Objectives The potential benefit of convalescent plasma (CP) therapy for coronavirus disease
2019 (COVID-19) is highest when administered early after symptom onset. Our objective …

[PDF][PDF] … TREATMENT BY MANTLE FIELD RADIOTHERAPY IN HODGKIN LYMPHOMA SURVIVORS ELENA M. VAN LEEUWEN-SEGARCEANU, MD,* LUCILLE DA …

S PILLEN - Int. J. Radiation Oncology Biol. Phys, 2012 - academia.edu
Conclusions: Many patients previously treated by mantle field radiotherapy develop severe
atrophy and weakness of the neck muscles. Neck muscles within the radiation field show …